about
Melanoma: a model for testing new agents in combination therapies.Effects of nuclear factor-κB and ERK signaling transduction pathway inhibitors on human melanoma cell proliferation in vitro.'Malignant melanoma microecosystem': Immunohistopathological insights into the stromal cell phenotype.NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular-targeted therapy in malignant melanoma.
@en
Molecular-targeted therapy in malignant melanoma.
@nl
type
label
Molecular-targeted therapy in malignant melanoma.
@en
Molecular-targeted therapy in malignant melanoma.
@nl
prefLabel
Molecular-targeted therapy in malignant melanoma.
@en
Molecular-targeted therapy in malignant melanoma.
@nl
P2860
P356
P1476
Molecular-targeted therapy in malignant melanoma.
@en
P2093
Michael B Atkins
Ryan J Sullivan
P2860
P304
P356
10.1586/ERA.09.20
P577
2009-05-01T00:00:00Z